Aster Capital Management (Difc) LTD Viridian Therapeutics, Inc.\De Transaction History
Aster Capital Management (Difc) LTD
- $198 Billion
- Q3 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 1,632 shares of VRDN stock, worth $46,903. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,632Holding current value
$46,903% of portfolio
0.02%Shares
4 transactions
Others Institutions Holding VRDN
# of Institutions
188Shares Held
83.9MCall Options Held
50.5KPut Options Held
94.1K-
Deep Track Capital, LP Greenwich, CT5.38MShares$155 Million3.65% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$137 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.43MShares$127 Million8.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$125 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$112 Million12.69% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $1.15B
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...